Get Premium to unlock powerful stock data
NAS:NVAX (USA)  
Novavax Inc logo

Novavax Inc

$ 57.15 +5.72 (+11.12%) 04:00 PM EST
P/E:
At Loss
P/B:
68.36
Market Cap:
$ 4.47B
Enterprise V:
$ 2.89B
Volume:
6.37M
Avg Vol (2M):
7.00M
Also Trade In:
Volume:
6.37M
Market Cap $:
4.47B
PE Ratio:
At Loss
Avg Vol (2-Month):
7.00M
Enterprise Value $:
2.89B
PB Ratio:
68.36
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Novavax Inc
NAICS : 325414 SIC : 2836
21 Firstfield Road, Gaithersburg, MD, USA, 20878
Description
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
Name Current Vs Industry Vs History
Cash-To-Debt 3.57
Equity-to-Asset 0.02
Debt-to-Equity 6.74
Debt-to-EBITDA -0.35
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.8
Distress
Grey
Safe
Beneish M-Score -1.88
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.92
9-Day RSI 58.27
14-Day RSI 54.07
6-1 Month Momentum % -61.33
12-1 Month Momentum % -73.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.04
Quick Ratio 0.99
Cash Ratio 0.69
Days Inventory 2560.28
Days Sales Outstanding 62.45
Days Payable 2445.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -58

Financials (Next Earnings Date:2022-08-05 Est.)

NVAX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:NVAX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,303.731
EPS (TTM) ($) -17.68
Beta 1.09
Volatility % 91.44
14-Day RSI 54.07
14-Day ATR ($) 5.295213
20-Day SMA ($) 46.0315
12-1 Month Momentum % -73.94
52-Week Range ($) 34.88 - 277.7999
Shares Outstanding (Mil) 78.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novavax Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More